I'm LongbridgeAI, I can summarize articles.Texas Instruments beat Q3 estimates with $6.06B revenue and raised Q4 guidance, yet shares slipped 1.7%. Following the results, most analysts raised price targets: Rosenblatt to $360, Stifel to $370, and JP Morgan to $365. Mizuho lowered its target to $290, while Barclays raised it to $280.
Texas Instruments Inc. (NASDAQ:TXN) on Wednesday posted upbeats third-quarter fiscal 2026 results and issued strong forward guidance.
Texas Instruments reported quarterly earnings of $2.62 per share, which beat the analyst consensus estimate of $2.41, per Benzinga Pro data. The company advised that EPS included a one-cent reduction that was not in its original guidance. Quarterly revenue of $6.06 billion beat the Street estimate of $5.92 billion and was up from $4.74 billion in the same period last year.
Texas Instruments expects fourth quarter GAAP EPS of $2.45-$2.79, versus the $2.29 analyst estimate, and revenue between $5.8 billion and $6.3 billion, versus the $5.73 billion estimate.
Texas Instruments shares slipped 1.7% to trade at $279.95 on Thursday.
These analysts made changes to their price targets on Texas Instruments following earnings announcement.
- Mizuho analyst Vijay Rakesh maintained the stock with a Neutral and lowered the price target from $305 to $290.
- Rosenblatt analyst Kevin Cassidy maintained the stock with a Buy and raised the price target from $350 to $360.
- Stifel analyst Tore Svanberg maintained the stock with a Buy and raised the price target from $360 to $370.
- JP Morgan analyst Harlan Sur maintained the stock with an Overweight rating and raised the price target from $340 to $365.
- Barclays analyst Tom O’Malley maintained the stock with an Equal-Weight rating and raised the price target from $250 to $280.
Photo via Shutterstock
Login to unlock746characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.